In 2013, Dr Robb founded BioPharmaPotentials which specializes in animal health product development providing both consulting services and exquisite execution of regulatory and development strategies to assure the full potential of new or current chemical or biologic entities. Scope of engagements varies from traditional consulting roles to serving as Chief Scientific and or Veterinary Program Officer for early phase global clients. Some concurrent additional roles include Chief of Development Strategy for Anivive Life Sciences, Chief Veterinary Officer for U.S. Biologic Inc, Director of Clinical Programs for Likarda Bio and  Managing  Partner PEDCO LLC. Dr Robb also serves as Chief Veterinary Officer for Healthy Cow Corp (HC) managing research/development and regulatory activities for HC’s first market entry ProPreg a ready to use propriety formulation of three live GRAS lactobacilli to support a healthy microbiome in cattle.

Dr. Robb received his B.S. in Animal Science (with honors and distinction) from Cornell University in 1977 and his D.V.M. in 1981.  He practiced veterinary medicine in northern N.Y. before completing an M.S. in epidemiology at the University of Pennsylvania. He completed a residency in Veterinary Nutrition and is Board Certified in Veterinary Clinical Nutrition.

Following clinical practice and serving as a Lecturer at the University of Pennsylvania, Dr Robb in 1986 moved to product development at the American Cyanamid Company holding various technical and business/marketing roles in Animal Health.  Later at The Upjohn Company, Kalamazoo, MI he served as Director and Senior Director, Worldwide Animal Health Clinical Research and Product Development. He served in this role at Pharmacia and Upjohn and at Pharmacia Corp.  In addition he had responsibilities for Technology Assessment and Business Development. Pfizer Inc. acquired Pharmacia and Dr. Robb held various roles within Pfizer including Director Senior Director, Biologicals Development, and Senior Director for Market Support, Executive Director, and Global Project Development & Clinical Research and in 2007 became Sr. Director and Head of Research for Embrex Inc., a wholly owned subsidiary of Pfizer Animal Health with a focus on in ovo vaccination and poultry vaccines.

In Feb 2008 Dr Robb was appointed as Vice President, Research and Development at Boehringer Ingelheim Vetmedica Inc., (BIVI) based in St Joseph, Missouri. Dr. Robb grew this research and development organization in the US from 90 FTEs to > 240 FTE and accelerated research investment from < M$30 year to >M$70 (US).  In 2013 Dr Robb joined Ceva Animal Health as Vice President of Business Development and later took on roles as Vice President for Pharmaceutical Research in the US. In late 2014 he was named as Chief Scientific Officer of Parnell Veterinary Pharmaceuticals. Parnell (NASDAQ- Parnell) completed an IPO in June 2014. Dr Robb left Parnell in December 2015.

Dr. Robb is an experienced leader building successful innovative global teams that have successfully registered new veterinary products with current annual sales> $500M (US).  His scientific interests include internal medicine, infectious diseases, and production diseases of livestock, the regulation of veterinary drugs, food safety and clinical trial design/ epidemiology. He lead global project teams and research organizations that delivered ‘game changing’ global pharmaceutical and biological (vaccine) projects that delivered value thru innovation  including  many of the most valuable animal health brand families in common use by veterinarians, producers and pet owners around the world.